This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Formulex Pharma Innovations Ltd., Nasus Pharma Ltd.. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: Tair Lapidot: Innovator in Pharmaceutical Compositions
Introduction
Tair Lapidot is a notable inventor based in Lapid, Israel. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of intranasal delivery systems. With a focus on addressing critical health issues, his work has garnered attention in the medical community.
Latest Patents
Tair Lapidot holds 2 patents that showcase his innovative approach to drug delivery. His latest patents include "Dry powder compositions for intranasal delivery," which feature an opioid receptor antagonist, such as naloxone, as an active ingredient. These compositions are designed for effective treatment of opioid overdose by administering a therapeutically effective amount intranasally. Another patent focuses on a pharmaceutical composition in dry powder form that includes solid particles of at least one opioid receptor antagonist and two types of solid particles, further enhancing the delivery method for naloxone.
Career Highlights
Throughout his career, Tair Lapidot has worked with various companies, including Formulex Pharma Innovations Ltd. and Nasus Pharma Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical technology.
Collaborations
Tair has collaborated with notable professionals in the field, including Galia Temtsin-Krayz and Dalia Megiddo. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Tair Lapidot's contributions to pharmaceutical innovations, particularly in intranasal delivery systems, highlight his commitment to improving healthcare solutions. His patents and collaborations reflect a dedication to addressing critical health challenges, making him a significant figure in the field of pharmaceutical inventions.